Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMC 2180966)

Published in J Exp Med on November 01, 1977

Authors

R F Kibler, R B Fritz, F Chou, Jen Chou C-H, N Y Peacocke, N M Brown, D E McFarlin

Articles citing this

A sequence pattern common to T cell epitopes. EMBO J (1988) 4.02

Homeostatic control of immunity by TCR peptide-specific Tregs. J Clin Invest (2004) 1.34

In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J Clin Invest (1994) 1.20

Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP). J Exp Med (1989) 1.12

Differences in the repertoire of the Lewis rat T cell response to self and non-self myelin basic proteins. J Exp Med (1988) 1.09

Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes. Proc Natl Acad Sci U S A (1985) 0.96

An experimental model of autoimmune pancreatitis in the rat. Am J Pathol (2005) 0.88

Contrasting immunopathogenic properties of highly homologous peptides from rat and human thyroglobulin. Immunology (1997) 0.86

Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models. Inflammopharmacology (2014) 0.84

Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis. Immunology (1990) 0.81

Genetic resistance to the induction of experimental allergic encephalomyelitis in Lewis rats. I. Genetic analysis of an apparent mutant strain with phenotypic resistance to experimental allergic encephalomyelitis. J Exp Med (1981) 0.80

A pathogenic autoimmune process targeted at a surrogate epitope. J Exp Med (1994) 0.78

Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody. Acta Neuropathol Commun (2015) 0.78

Articles by these authors

Immunological aspects of demyelinating diseases. Annu Rev Immunol (1992) 4.39

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (1990) 3.50

Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer (1994) 3.25

Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J Immunol (1981) 3.15

Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr (2001) 2.97

Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol (1991) 2.80

Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature (1974) 2.55

Ataxia-telangiectasia. Medicine (Baltimore) (1972) 2.50

Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol (2006) 2.37

The Effect of Heparin upon Intra-abdominal Adhesions in Rabbits. Ann Surg (1947) 2.35

Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature (1988) 2.27

Impact of cleaning and other interventions on the reduction of hospital-acquired Clostridium difficile infections in two hospitals in England assessed using a breakpoint model. J Hosp Infect (2013) 2.11

Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol (1990) 2.07

Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications. Ann N Y Acad Sci (1966) 2.02

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol (1991) 2.00

Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature (1984) 1.95

Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature (1993) 1.89

Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest (1981) 1.84

A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med (1991) 1.84

Phospholipid-sensitive Ca2+-dependent protein kinase from heart. II. Substrate specificity and inhibition by various agents. J Biol Chem (1982) 1.83

Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol (1995) 1.76

Multiple sclerosis (first of two parts). N Engl J Med (1982) 1.72

Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J Immunol (1977) 1.58

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol (1993) 1.58

Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J Immunol (1985) 1.55

Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell Immunol (1985) 1.52

Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor. J Immunol (1969) 1.51

A radioimmunoassay for human antigen-antibody complexes in clinical material. J Immunol (1975) 1.51

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol (1992) 1.50

Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. J Exp Med (1985) 1.46

Meticillin-resistant Staphylococcus aureus in the community: homeless are also at risk. J Hosp Infect (2008) 1.46

Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol (1992) 1.43

Immunoglobulin A production in ataxia telangiectasia. Science (1965) 1.41

Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol (1992) 1.40

Real-time PCR investigation into the importance of Fusobacterium necrophorum as a cause of acute pharyngitis in general practice. J Med Microbiol (2004) 1.38

An unusual form of diabetes mellitus in ataxia telangiectasia. N Engl J Med (1970) 1.38

Immunoglobulin metabolism in ataxia telangiectasia. J Clin Invest (1968) 1.38

Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. J Immunol (1983) 1.35

Prophylactic oral fluconazole and candida fungaemia. Lancet (1991) 1.33

The germline repertoire of T cell receptor beta-chain genes in patients with chronic progressive multiple sclerosis. J Neuroimmunol (1989) 1.32

Characterization of T cell lines and clones from SJL/J and (BALB/c x SJL/J)F1 mice specific for myelin basic protein. J Immunol (1985) 1.31

Intravenous drug users and AIDS: risk behaviors. Am J Drug Alcohol Abuse (1991) 1.31

Contact sensitivity in the pig. Immunology (1973) 1.30

Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin. Nature (1981) 1.30

Response of bone marrow to MC29 avian leukosis virus in vitro. Cancer Res (1969) 1.30

Genistein suppresses mammary cancer in rats. Carcinogenesis (1995) 1.29

Purification to homogeneity, characterization and monoclonal antibodies of phospholipid-sensitive Ca2+-dependent protein kinase from spleen. Biochem J (1983) 1.27

Immunological studies in tropical spastic paraparesis. Ann Neurol (1990) 1.26

Recurrent experimental allergic encephalomyelitis in the Lewis rat. J Immunol (1974) 1.26

Mycobacterial contamination of fibreoptic bronchoscopes. J Hosp Infect (1995) 1.25

Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia (1993) 1.25

Clonal expansion of cells with trisomy of chromosomes 12 and X in an EBV-transformed lymphoblastoid cell line and establishment of a tumorigenic monoclonal cell line (48,XX,+X,+12). Cytogenet Cell Genet (1993) 1.24

Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Invest (1980) 1.24

Ciprofloxacin resistance in Salmonella paratyphi A. J Antimicrob Chemother (1994) 1.21

Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides. Science (1973) 1.21

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol (1993) 1.20

Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J Immunol (1983) 1.20

Lymph node function and lymphocyte circulation in the pig. Adv Exp Med Biol (1973) 1.20

An eight-year survey of the antimicrobial susceptibility patterns of 85,971 bacteria isolated from patients in a district general hospital and the local community. J Antimicrob Chemother (1993) 1.19

Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol (1990) 1.18

Thymic epithelial cell contains acetylcholine receptor. Lancet (1977) 1.18

Multiple sclerosis (second of two parts). N Engl J Med (1982) 1.18

Basis of microheterogeneity of myelin basic protein. J Biol Chem (1976) 1.17

Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab Invest (1984) 1.17

Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus (MRSA) infection at a teaching hospital. QJM (1998) 1.16

Differences between the two myelin basic proteins of the rat central nervous system. A deletion in the smaller protein. Biochim Biophys Acta (1972) 1.15

Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. J Immunol (1993) 1.15

Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis. Ann Neurol (1988) 1.14

Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis (1996) 1.14

Value of CT-guided biopsy in the diagnosis of septic discitis. J Clin Pathol (2008) 1.13

Presentation of myelin basic protein by murine cerebral vascular endothelial cells. J Immunol (1985) 1.11

Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest (1982) 1.11

The major site of guinea-pig myelin basic protein encephalitogenic in Lewis rats. J Neurochem (1977) 1.11

Scrapie in immunologically deficient mice. Nature (1971) 1.10

Encephalitogenic protein: structure. Science (1969) 1.09

The immune response against myelin basic protein in two strains of rat with different genetic capacity to develop experimental allergic encephalomyelitis. J Exp Med (1975) 1.09

Avian oncornavirus group-specific antigen: detection and quantification by radioimmunoassay. J Virol (1973) 1.09

Human cellular immune response to measles virus polypeptides. J Virol (1984) 1.07

Purification of measles virus with preservation of infectivity and antigenicity. J Gen Virol (1979) 1.06

Cellular immune response to measles, mumps, and vaccinia viruses in multiple sclerosis. Ann Neurol (1979) 1.06

Astrocytes: auxiliary cells for immune responses in the central nervous system? Immunol Today (1990) 1.05

Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia. Clin Microbiol Infect (2009) 1.05

Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet (1992) 1.05

Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J Immunol (1982) 1.05

Immune reactivity of the purified hemagglutinin of measles virus. Infect Immun (1981) 1.04

Does myasthenic serum bind to the neuromuscular junction? Ann N Y Acad Sci (1966) 1.03

Strain MC29 avian leukosis virus release by chick embryo cells infected with the agent. Proc Soc Exp Biol Med (1969) 1.03

Bacteriology and antimicrobial choice in hepatolithiasis. Am J Infect Control (2000) 1.03

Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol (1993) 1.02

Radioiodination of antibodies and adsorbed to insoluble antigens. J Immunol (1967) 1.01

Evaluation of the structural proteins of the hamster neurotropic strain of measles virus with monoclonal antibodies. J Neuroimmunol (1986) 1.01

The immune response of Lewis rats to peptide 68-88 of guinea pig myelin basic protein. I. T cell determinants. J Immunol (1979) 1.01